Vertex Pharmaceuticals is diversifying from its cystic fibrosis dominance into pain and other markets. Check out our ...

Prepacked salt, seasonings and instant noodles are among the items which will be graded from A to D from mid-2027, under an ...

We should not lose sight of how wonderfully productive the biomedical research enterprise — now under threat — can be. The ...

Xenophon's ancient Greek army's encounter with hallucinogenic honey left them incapacitated, highlighting an unusual moment in warfare.

Ask any smoker who has tried to quit and they’ll tell you it isn’t easy. But a recent study offers a surprising glimmer of ...

Creators of an innovative pacifier believe it will transform neonatal care. According to team lead and associate professor ...

Sea’s pre-clinical stage neurotherapeutic synthetic oral molecules act at the neurotransmitter glutamate pathway on two clinically validated targets in the CNS (central nervous system) ...

Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for ...

describe our current understanding of the mechanisms that regulate ion channel delivery to specific neuronal compartments, with a focus on the distribution of voltage-gated sodium channels in ...

DWTX Chairman and CEO Greg Duncan stated, “We appreciate the consideration Nasdaq has shown Dogwood Therapeutics, Inc.” He continued, “The Company has a strong cash position of $17.5 million as of the ...

For the first time, Guyana has given its blessing for a tour company to start bringing visitors into what’s left of Jonestown ...